JP2010535200A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010535200A5 JP2010535200A5 JP2010519175A JP2010519175A JP2010535200A5 JP 2010535200 A5 JP2010535200 A5 JP 2010535200A5 JP 2010519175 A JP2010519175 A JP 2010519175A JP 2010519175 A JP2010519175 A JP 2010519175A JP 2010535200 A5 JP2010535200 A5 JP 2010535200A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- morpholin
- ylmethyl
- pyridin
- indole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95263407P | 2007-07-30 | 2007-07-30 | |
| PCT/SE2008/050895 WO2009017452A1 (en) | 2007-07-30 | 2008-07-29 | New crystalline forms of 2 -hydroxy- 3- [5- (morpholin- 4- ylmethyl) pyridin-2-yl] ih- indole- 5 -carbonitrile citrate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010535200A JP2010535200A (ja) | 2010-11-18 |
| JP2010535200A5 true JP2010535200A5 (enExample) | 2012-09-06 |
Family
ID=40304559
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010519175A Pending JP2010535200A (ja) | 2007-07-30 | 2008-07-29 | ２−ヒドロキシ−３−［５−（モルホリン−４−イルメチル）ピリジン−２−イル］−１ｈ−インドール−５−カルボニトリル・クエン酸塩の新しい結晶形態 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20100267720A1 (enExample) |
| EP (1) | EP2183247B1 (enExample) |
| JP (1) | JP2010535200A (enExample) |
| CN (1) | CN101772497A (enExample) |
| WO (1) | WO2009017452A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| CN102949376A (zh) * | 2011-08-25 | 2013-03-06 | 天津药物研究院 | 一种含阿戈美拉汀的肠溶胶囊的药用组合物 |
| WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| CN115130566B (zh) * | 2022-06-20 | 2025-04-11 | 浙江大学 | 一种基于自注意力机制的拉曼光谱分类方法 |
| EP4467137A1 (en) * | 2023-05-25 | 2024-11-27 | Universidad Autónoma de Madrid | Treatment of frontotemporal dementia or frontotemporal lobar dementia |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GT200200234A (es) * | 2001-12-06 | 2003-06-27 | Compuestos cristalinos novedosos | |
| SE0200979D0 (sv) * | 2002-03-28 | 2002-03-28 | Astrazeneca Ab | New compounds |
| SA07280004B1 (ar) * | 2006-02-02 | 2011-10-29 | استرازينيكا ايه بي | ملح سترات من مركب 2- هيدروكسي –3- [5- (مورفولين –4- يل ميثيل) بيريدين –2- يل] 1h- إندول –5- كربونيتريل سترات |
| WO2007089193A1 (en) * | 2006-02-02 | 2007-08-09 | Astrazeneca Ab | A process for preparing 2-hydroxy-3- [5- (morpholin-4-ylmethyl)pyridin-2-yl] lh-indole-5-carbonitrile as a free base or salts thereof |
| US8101750B2 (en) * | 2007-04-18 | 2012-01-24 | Astrazeneca Ab | Process for the manufacturing of the compound 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1H-indole-5-carbonitrile 701 |
-
2008
- 2008-07-29 JP JP2010519175A patent/JP2010535200A/ja active Pending
- 2008-07-29 CN CN200880101217A patent/CN101772497A/zh active Pending
- 2008-07-29 EP EP08826701A patent/EP2183247B1/en not_active Not-in-force
- 2008-07-29 WO PCT/SE2008/050895 patent/WO2009017452A1/en not_active Ceased
- 2008-07-29 US US12/671,236 patent/US20100267720A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010535200A5 (enExample) | ||
| JP2012532125A5 (enExample) | ||
| JP2011513485A5 (enExample) | ||
| JP2017531020A5 (enExample) | ||
| JP2013502431A5 (enExample) | ||
| JP6592512B2 (ja) | 三環式アトロプ異性体の化合物 | |
| JP2009535340A5 (enExample) | ||
| JP2008520589A5 (enExample) | ||
| JP7794910B2 (ja) | Ｅａａｔ２活性化因子およびその使用方法 | |
| RU2011152516A (ru) | Производные 2-карбоксамид-7-пиперазинил-бензофурана 774 | |
| JP2014518554A (ja) | スフィンゴシン−１リン酸受容体調節剤としての置換二環式メチルアミン誘導体 | |
| JP2019513745A5 (enExample) | ||
| JP2021513972A (ja) | 社会的機能障害の治療方法 | |
| JP2017533237A (ja) | 強力なγ−セクレターゼモジュレータ | |
| JP2019014762A (ja) | ニロチニブ塩酸塩の多形形態 | |
| JP2001511131A (ja) | 月経前不快障害の処置 | |
| JP2010535200A (ja) | ２−ヒドロキシ−３−［５−（モルホリン−４−イルメチル）ピリジン−２−イル］−１ｈ−インドール−５−カルボニトリル・クエン酸塩の新しい結晶形態 | |
| WO2016199878A1 (ja) | シグマ受容体結合剤 | |
| RU2008131906A (ru) | Новая цитратная соль производного индола и ее фармацевтическое применение | |
| JP2009525324A5 (enExample) | ||
| WO2003070728A3 (en) | Azabicyclo-substituted benzoylamides and thioamides for treatment of cns-related disorders | |
| CN1033454C (zh) | 4-[(2-苯并噻唑基)甲氨基]-α-[(3，4-二氟苯氧基)甲基]-1-哌啶乙醇的制备方法 | |
| JP2012510471A (ja) | （ｒ）−５−（（ｅ）−２−（ピロリジン−３−イルビニル）ピリミジンの合成および新規の塩形態 | |
| JP2020507567A5 (enExample) | ||
| JP2018522915A5 (enExample) |